167 related articles for article (PubMed ID: 34768883)
1. The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target.
Çakılkaya P; Sørensen RR; Jürgensen HJ; Krigslund O; Gårdsvoll H; Nielsen CF; Santoni-Rugiu E; Behrendt N; Engelholm LH
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768883
[TBL] [Abstract][Full Text] [Related]
2. The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.
Nielsen CF; van Putten SM; Lund IK; Melander MC; Nørregaard KS; Jürgensen HJ; Reckzeh K; Christensen KR; Ingvarsen SZ; Gårdsvoll H; Jensen KE; Hamerlik P; Engelholm LH; Behrendt N
Oncotarget; 2017 Jul; 8(27):44605-44624. PubMed ID: 28574834
[TBL] [Abstract][Full Text] [Related]
3. The collagen receptor uPARAP/Endo180.
Engelholm LH; Ingvarsen S; Jürgensen HJ; Hillig T; Madsen DH; Nielsen BS; Behrendt N
Front Biosci (Landmark Ed); 2009 Jan; 14(6):2103-14. PubMed ID: 19273187
[TBL] [Abstract][Full Text] [Related]
4. TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.
Caley MP; Kogianni G; Adamarek A; Gronau JH; Rodriguez-Teja M; Fonseca AV; Mauri F; Sandison A; Rhim JS; Pchejetski D; Palmieri C; Cobb JP; Waxman J; Sturge J
J Pathol; 2012 Apr; 226(5):775-83. PubMed ID: 22072289
[TBL] [Abstract][Full Text] [Related]
5. The collagen receptor uPARAP/Endo180 regulates collectins through unique structural elements in its FNII domain.
Nørregaard KS; Krigslund O; Behrendt N; Engelholm LH; Jürgensen HJ
J Biol Chem; 2020 Jul; 295(27):9157-9170. PubMed ID: 32424040
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells.
Takahashi S; Yamada-Okabe H; Hamada K; Ohta S; Kawase T; Yoshida K; Toda M
J Neurooncol; 2011 Jun; 103(2):267-76. PubMed ID: 20845060
[TBL] [Abstract][Full Text] [Related]
7. A novel functional role of collagen glycosylation: interaction with the endocytic collagen receptor uparap/ENDO180.
Jürgensen HJ; Madsen DH; Ingvarsen S; Melander MC; Gårdsvoll H; Patthy L; Engelholm LH; Behrendt N
J Biol Chem; 2011 Sep; 286(37):32736-48. PubMed ID: 21768090
[TBL] [Abstract][Full Text] [Related]
8. uPARAP/Endo180: a multifaceted protein of mesenchymal cells.
Gucciardo F; Pirson S; Baudin L; Lebeau A; Noël A
Cell Mol Life Sci; 2022 Apr; 79(5):255. PubMed ID: 35460056
[TBL] [Abstract][Full Text] [Related]
9. Uptake of denatured collagen into hepatic stellate cells: evidence for the involvement of urokinase plasminogen activator receptor-associated protein/Endo180.
Mousavi SA; Sato M; Sporstøl M; Smedsrød B; Berg T; Kojima N; Senoo H
Biochem J; 2005 Apr; 387(Pt 1):39-46. PubMed ID: 15506989
[TBL] [Abstract][Full Text] [Related]
10. The non-phagocytic route of collagen uptake: a distinct degradation pathway.
Madsen DH; Ingvarsen S; Jürgensen HJ; Melander MC; Kjøller L; Moyer A; Honoré C; Madsen CA; Garred P; Burgdorf S; Bugge TH; Behrendt N; Engelholm LH
J Biol Chem; 2011 Jul; 286(30):26996-7010. PubMed ID: 21652704
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.
Caley MP; King H; Shah N; Wang K; Rodriguez-Teja M; Gronau JH; Waxman J; Sturge J
Clin Exp Metastasis; 2016 Feb; 33(2):151-65. PubMed ID: 26567111
[TBL] [Abstract][Full Text] [Related]
12. The endocytic receptor uPARAP is a regulator of extracellular thrombospondin-1.
Nørregaard KS; Jürgensen HJ; Ingvarsen SZ; Heltberg SS; Hagensen CE; Gårdsvoll H; Madsen DH; Jensen ON; Engelholm LH; Behrendt N
Matrix Biol; 2022 Aug; 111():307-328. PubMed ID: 35878760
[TBL] [Abstract][Full Text] [Related]
13. Expression and crystallographic studies of the ligand-binding region of the human endocytic collagen receptor uPARAP.
Yuan C; Huang JH; Liu M; Huang M
Acta Crystallogr F Struct Biol Commun; 2015 Nov; 71(Pt 11):1442-7. PubMed ID: 26527274
[TBL] [Abstract][Full Text] [Related]
14. AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.
Rodriguez-Teja M; Gronau JH; Breit C; Zhang YZ; Minamidate A; Caley MP; McCarthy A; Cox TR; Erler JT; Gaughan L; Darby S; Robson C; Mauri F; Waxman J; Sturge J
J Pathol; 2015 Mar; 235(4):581-92. PubMed ID: 25408555
[TBL] [Abstract][Full Text] [Related]
15. The urokinase receptor associated protein (uPARAP/endo180): a novel internalization receptor connected to the plasminogen activation system.
Engelholm LH; Nielsen BS; Danø K; Behrendt N
Trends Cardiovasc Med; 2001 Jan; 11(1):7-13. PubMed ID: 11413046
[TBL] [Abstract][Full Text] [Related]
16. Complex determinants in specific members of the mannose receptor family govern collagen endocytosis.
Jürgensen HJ; Johansson K; Madsen DH; Porse A; Melander MC; Sørensen KR; Nielsen C; Bugge TH; Behrendt N; Engelholm LH
J Biol Chem; 2014 Mar; 289(11):7935-47. PubMed ID: 24500714
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of uPARAP/Endo180 during culture activation of rat hepatic stellate cells and its presence in hepatic stellate cell lines from different species.
Mousavi SA; Fønhus MS; Berg T
BMC Cell Biol; 2009 May; 10():39. PubMed ID: 19432973
[TBL] [Abstract][Full Text] [Related]
18. Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy.
Curino AC; Engelholm LH; Yamada SS; Holmbeck K; Lund LR; Molinolo AA; Behrendt N; Nielsen BS; Bugge TH
J Cell Biol; 2005 Jun; 169(6):977-85. PubMed ID: 15967816
[TBL] [Abstract][Full Text] [Related]
19. Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis.
Madsen DH; Jürgensen HJ; Ingvarsen S; Melander MC; Vainer B; Egerod KL; Hald A; Rønø B; Madsen CA; Bugge TH; Engelholm LH; Behrendt N
J Pathol; 2012 May; 227(1):94-105. PubMed ID: 22294280
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells.
Schnack Nielsen B; Rank F; Engelholm LH; Holm A; Danø K; Behrendt N
Int J Cancer; 2002 Apr; 98(5):656-64. PubMed ID: 11920633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
